Notice: Prescription Drug List (PDL): Hyoscine butylbromide
The purpose of this Notice of Amendment is to notify that Health Canada will switch injectable Hyoscine butylbromide to prescription status from ethical status for human use by adding it to the Human Prescription Drug List (PDL). Injectable Hyoscine butylbromide is already listed on the Veterinary Prescription Drug List.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Notice: Prescription Drug List (PDL): Hyoscine butylbromideHTMLEnglish publication HTML
-
Notice: Prescription Drug List (PDL): Hyoscine butylbromideHTMLFrench publication HTML
Similar records